Logo image of SLQT

SELECTQUOTE INC (SLQT) Stock Fundamental Analysis

NYSE:SLQT - New York Stock Exchange, Inc. - US8163073005 - Common Stock - Currency: USD

4.57  -0.92 (-16.76%)

After market: 4.7 +0.13 (+2.84%)

Fundamental Rating

3

SLQT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 143 industry peers in the Insurance industry. The financial health of SLQT is average, but there are quite some concerns on its profitability. SLQT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year SLQT has reported negative net income.
In the past year SLQT had a positive cash flow from operations.
In the past 5 years SLQT reported 4 times negative net income.
SLQT had negative operating cash flow in 4 of the past 5 years.
SLQT Yearly Net Income VS EBIT VS OCF VS FCFSLQT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

SLQT's Return On Assets of -1.08% is on the low side compared to the rest of the industry. SLQT is outperformed by 85.82% of its industry peers.
With a Return On Equity value of -4.23%, SLQT is not doing good in the industry: 81.56% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 6.60%, SLQT belongs to the top of the industry, outperforming 83.69% of the companies in the same industry.
Industry RankSector Rank
ROA -1.08%
ROE -4.23%
ROIC 6.6%
ROA(3y)-10.24%
ROA(5y)-4.72%
ROE(3y)-34.57%
ROE(5y)-17.64%
ROIC(3y)N/A
ROIC(5y)N/A
SLQT Yearly ROA, ROE, ROICSLQT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

SLQT has a worse Operating Margin (6.22%) than 64.54% of its industry peers.
In the last couple of years the Operating Margin of SLQT has declined.
SLQT has a Gross Margin of 43.15%. This is amongst the best in the industry. SLQT outperforms 92.91% of its industry peers.
In the last couple of years the Gross Margin of SLQT has declined.
Industry RankSector Rank
OM 6.22%
PM (TTM) N/A
GM 43.15%
OM growth 3Y-38.22%
OM growth 5Y-30.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.91%
GM growth 5Y-8.11%
SLQT Yearly Profit, Operating, Gross MarginsSLQT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

SLQT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SLQT has more shares outstanding
The number of shares outstanding for SLQT has been increased compared to 5 years ago.
SLQT has about the same debt/assets ratio as last year.
SLQT Yearly Shares OutstandingSLQT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SLQT Yearly Total Debt VS Total AssetsSLQT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 1.85 indicates that SLQT is not a great score, but indicates only limited risk for bankruptcy at the moment.
SLQT has a Altman-Z score of 1.85. This is amongst the best in the industry. SLQT outperforms 87.94% of its industry peers.
SLQT has a debt to FCF ratio of 82.74. This is a negative value and a sign of low solvency as SLQT would need 82.74 years to pay back of all of its debts.
With a Debt to FCF ratio value of 82.74, SLQT is not doing good in the industry: 76.60% of the companies in the same industry are doing better.
A Debt/Equity ratio of 2.10 is on the high side and indicates that SLQT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.10, SLQT is doing worse than 93.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 82.74
Altman-Z 1.85
ROIC/WACC0.74
WACC8.91%
SLQT Yearly LT Debt VS Equity VS FCFSLQT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.92 indicates that SLQT should not have too much problems paying its short term obligations.
The Current ratio of SLQT (1.92) is better than 91.49% of its industry peers.
SLQT has a Quick Ratio of 1.92. This is a normal value and indicates that SLQT is financially healthy and should not expect problems in meeting its short term obligations.
SLQT's Quick ratio of 1.92 is amongst the best of the industry. SLQT outperforms 91.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.92
SLQT Yearly Current Assets VS Current LiabilitesSLQT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.97% over the past year.
Looking at the last year, SLQT shows a very strong growth in Revenue. The Revenue has grown by 25.67%.
The Revenue has been growing by 31.39% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)70.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
Revenue 1Y (TTM)25.67%
Revenue growth 3Y12.43%
Revenue growth 5Y31.39%
Sales Q2Q%18.65%

3.2 Future

The Earnings Per Share is expected to grow by 50.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, SLQT will show a quite strong growth in Revenue. The Revenue will grow by 15.45% on average per year.
EPS Next Y33.62%
EPS Next 2Y50.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.22%
Revenue Next 2Y15.45%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SLQT Yearly Revenue VS EstimatesSLQT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SLQT Yearly EPS VS EstimatesSLQT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

SLQT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 84.01, which means the current valuation is very expensive for SLQT.
SLQT's Price/Forward Earnings ratio is rather expensive when compared to the industry. SLQT is more expensive than 80.85% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, SLQT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 84.01
SLQT Price Earnings VS Forward Price EarningsSLQT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 80

4.2 Price Multiples

SLQT's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SLQT indicates a slightly more expensive valuation: SLQT is more expensive than 76.60% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 91.43
EV/EBITDA 14.38
SLQT Per share dataSLQT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as SLQT's earnings are expected to grow with 50.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.3%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SLQT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SELECTQUOTE INC

NYSE:SLQT (2/21/2025, 8:04:00 PM)

After market: 4.7 +0.13 (+2.84%)

4.57

-0.92 (-16.76%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners37.85%
Inst Owner Change-1.03%
Ins Owners9.85%
Ins Owner Change1.82%
Market Cap786.68M
Analysts80
Price Target7.48 (63.68%)
Short Float %1.74%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)83.23%
Min EPS beat(2)-37.78%
Max EPS beat(2)204.25%
EPS beat(4)2
Avg EPS beat(4)54%
Min EPS beat(4)-37.78%
Max EPS beat(4)204.25%
EPS beat(8)5
Avg EPS beat(8)49.17%
EPS beat(12)7
Avg EPS beat(12)57.65%
EPS beat(16)8
Avg EPS beat(16)26.24%
Revenue beat(2)2
Avg Revenue beat(2)4.7%
Min Revenue beat(2)3.89%
Max Revenue beat(2)5.51%
Revenue beat(4)4
Avg Revenue beat(4)7.09%
Min Revenue beat(4)3.89%
Max Revenue beat(4)10.34%
Revenue beat(8)8
Avg Revenue beat(8)9.82%
Revenue beat(12)11
Avg Revenue beat(12)5.33%
Revenue beat(16)12
Avg Revenue beat(16)0.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)3.58%
EPS NQ rev (3m)13.73%
EPS NY rev (1m)31.67%
EPS NY rev (3m)29.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 84.01
P/S 0.54
P/FCF 91.43
P/OCF 41.03
P/B 2.41
P/tB 2.87
EV/EBITDA 14.38
EPS(TTM)-0.09
EYN/A
EPS(NY)0.05
Fwd EY1.19%
FCF(TTM)0.05
FCFY1.09%
OCF(TTM)0.11
OCFY2.44%
SpS8.46
BVpS1.89
TBVpS1.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -4.23%
ROCE 8.36%
ROIC 6.6%
ROICexc 6.68%
ROICexgc 7.01%
OM 6.22%
PM (TTM) N/A
GM 43.15%
FCFM 0.59%
ROA(3y)-10.24%
ROA(5y)-4.72%
ROE(3y)-34.57%
ROE(5y)-17.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-30.93%
ROICexcg growth 5Y-23.78%
ROICexc growth 3Y-29.33%
ROICexc growth 5Y-24.21%
OM growth 3Y-38.22%
OM growth 5Y-30.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.91%
GM growth 5Y-8.11%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 82.74
Debt/EBITDA 5.98
Cap/Depr 44.46%
Cap/Sales 0.73%
Interest Coverage 1.31
Cash Conversion 16.76%
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.92
Altman-Z 1.85
F-Score4
WACC8.91%
ROIC/WACC0.74
Cap/Depr(3y)73.19%
Cap/Depr(5y)111.33%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
EPS Next Y33.62%
EPS Next 2Y50.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.67%
Revenue growth 3Y12.43%
Revenue growth 5Y31.39%
Sales Q2Q%18.65%
Revenue Next Year16.22%
Revenue Next 2Y15.45%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y193.37%
EBIT growth 3Y-30.54%
EBIT growth 5Y-8.12%
EBIT Next Year99.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.73%
OCF growth 3YN/A
OCF growth 5Y168.1%